Tagged: dr. carme plasencia

March 1, 2017 @ 5:53 am By Erin Hobey  |  

Valued at 9,400,000€, Bionure is overfunding on Capital Cell, raising more than 975,422€ from over 210 investors for 9.27% equity for its neuroprotector and myelin regenerator drug which treat Multiple Sclerosis. Bionure is a biotech-based company that is developing a new drug for the treatment of multiple sclerosis, a… Read More

January 17, 2017 @ 6:15 am By Erin Hobey  |  

Aromics, a privately-owned development stage pharmaceutical company founded in 2005, is based in Barcelona, Spain and focused on developing novel first-in-class therapies for the treatment of human diseases. The company has received the seal of Innovative SME from MINECO and achieved different R&D awards from international,… Read More